06/26/2025
1:23 PM | UBS Group (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/26/2025
1:29 PM | UBS Group (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/06/2025
11:15 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2025
11:26 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2025
3:20 PM | UBS Group (Filer)
| Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers | |
05/08/2025
5:30 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2025
5:28 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/05/2025
1:56 PM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/01/2025
5:24 AM | Rapid7, Inc. (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G/A | |
04/30/2025
3:41 PM | Renalytix plc (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G/A | |
04/30/2025
3:15 PM | Renalytix plc (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for UBS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for UBS Group and its competitors with MarketBeat's FREE daily newsletter. |
04/30/2025
2:31 PM | UBS Group (Filed by)
Western Asset Investment Grade Opportunity Trust Inc. (Subject)
| Form SCHEDULE 13G | |
04/30/2025
2:48 PM | Color Star Technology Co., Ltd. (Subject)
Color Star Technology Co., Ltd. (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G/A | |
04/30/2025
10:44 AM | Infinera Corp (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G/A | |
04/30/2025
5:31 AM | UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2025
5:33 AM | UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2025
5:20 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2025
5:27 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2025
1:33 PM | CLOROX CO /DE/ (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G/A | |
04/25/2025
10:41 AM | CLOROX CO /DE/ (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G | |
04/17/2025
12:04 PM | UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/14/2025
2:40 PM | NORGES BANK (Filed by)
UBS Group (Subject)
| Form SCHEDULE 13G/A | |
03/17/2025
7:35 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/17/2025
7:24 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/17/2025
7:25 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/17/2025
7:26 AM | UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/17/2025
7:27 AM | UBS Group (Filer)
| Form IRANNOTICE | |
03/17/2025
6:51 AM | UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/17/2025
6:56 AM | UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/17/2025
6:41 AM | UBS Group (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/04/2025
5:07 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/25/2025
4:14 PM | Global Star Acquisition Inc. (Issuer)
Global Star Acquisition Inc. (Issuer)
Global Star Acquisition Inc. (Issuer)
Global Star Acquisition Inc. (Issuer)
UBS Group (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
8:49 AM | UBS Group (Filer)
| Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers | |
02/10/2025
9:59 AM | UBS Group (Filed by)
Vipshop Holdings Ltd (Subject)
| Form SCHEDULE 13G/A | |
02/10/2025
9:42 AM | PIMCO Access Income Fund (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G/A | |
02/10/2025
8:26 AM | Renalytix plc (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G | |
02/10/2025
7:59 AM | Amneal Pharmaceuticals, Inc. (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G/A | |
02/10/2025
8:13 AM | Liberty Broadband Corp (Subject)
Liberty Broadband Corp (Subject)
Liberty Broadband Corp (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G/A | |
02/10/2025
7:33 AM | Color Star Technology Co., Ltd. (Subject)
Color Star Technology Co., Ltd. (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G | |
02/05/2025
12:24 PM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/04/2025
8:32 AM | UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Post-Halving = Profit Season (Here’s How to Win It) (Ad) It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential.
We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks.
Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap.
And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it. The Most Profitable Phase of Crypto Just Started - PLUS Claim your $10 in Bitcoin |
02/04/2025
6:22 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/04/2025
6:26 AM | UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024
9:01 AM | UBS Group (Filer)
| Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers | |
11/08/2024
11:14 AM | NORGES BANK (Filed by)
UBS Group (Subject)
| Form SC 13G | |
11/08/2024
5:23 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/08/2024
5:26 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/06/2024
11:04 AM | Infinera Corp (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G | |
11/04/2024
9:49 AM | Rapid7, Inc. (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G | |
11/01/2024
8:00 AM | abrdn Income Credit Strategies Fund (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G/A | |
11/01/2024
6:13 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/01/2024
5:47 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/31/2024
9:43 AM | Thornburg Income Builder Opportunities Trust (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G | |
10/30/2024
2:18 PM | Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G/A | |
10/30/2024
10:30 AM | Liberty Broadband Corp (Subject)
Liberty Broadband Corp (Subject)
Liberty Broadband Corp (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G | |
10/30/2024
10:04 AM | Amneal Pharmaceuticals, Inc. (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G | |
10/30/2024
5:39 AM | UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2024
5:27 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2024
5:31 AM | UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2024
5:34 AM | UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2024
8:42 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2024
8:44 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2024
2:28 PM | ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences Inc. (Issuer)
UBS Group (Reporting)
| Form 4/A | |
09/05/2024
1:47 PM | ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences Inc. (Issuer)
UBS Group (Reporting)
| Form 3/A | |
09/03/2024
2:25 PM | UBS Group (Filer)
| Form N-PX
Annual Report of Proxy Voting Record of Registered Management Investment Company | |
08/29/2024
3:30 PM | ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences Inc. (Issuer)
UBS Group (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
11:11 AM | ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences Inc. (Issuer)
UBS Group (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/23/2024
7:33 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/23/2024
7:37 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/23/2024
7:27 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/23/2024
7:31 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2024
9:29 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024
6:24 AM | UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024
6:29 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024
6:22 AM | UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024
6:09 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024
6:12 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024
6:19 AM | UBS AG (Filer)
UBS Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/08/2024
11:55 AM | Sight Sciences, Inc. (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G/A | |
08/08/2024
11:48 AM | MARCUS CORP (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G/A | |
08/08/2024
10:36 AM | ASLAN Pharmaceuticals Ltd (Subject)
UBS Group (Filed by)
| Form SCHEDULE 13G/A | |
07/10/2024
1:24 PM | UBS Group (Reporting)
Volcon, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
8:36 AM | UBS Group (Reporting)
Volcon, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Free UBS Stock Alerts